Target intelligence / Profile preview

TTC23 antisense RNA 1 (TTC23-AS1)

Target
TTC23-AS1
Molecular classification
Long non-coding RNA (lncRNA), Antisense RNA, Other
01

Overview

TTC23 antisense RNA 1 (TTC23-AS1) is a human long non-coding RNA (lncRNA) transcribed from the opposite DNA strand of the TTC23 gene. As an antisense RNA, it does not encode a protein but is presumed to regulate gene expression, often impacting its overlapping or adjacent sense gene in cis or trans through mechanisms such as modulation of transcription, RNA stability, or chromatin organization. Specific functional studies or disease associations for TTC23-AS1 have not been reported, and it does not serve as a known therapeutic target, biomarker, or safety concern itself. The gene is located on human chromosome 15 (chr15:99139317-99145370, hg38). As with many antisense lncRNAs, TTC23-AS1 might play a role in the regulation of its sense gene TTC23, but direct evidence for biological or disease functions is currently lacking.

Other names
AC036108.3TTC23-AS1
02

Mechanism of action

Not applicable for drugs, but typical mechanisms for antisense lncRNAs include RNA-DNA, RNA-RNA, and RNA-protein interactions affecting transcription, mRNA stability, or chromatin structure

03

Biological functions

Regulation of gene expression (mostly at the transcription and post-transcriptional level)Likely modulation of neighboring sense gene (TTC23) via antisense mechanismsOther
04

Disease associations

No specific disease associations described for TTC23-AS1 itself, but antisense lncRNAs are frequently involved in cancer and various other diseases through regulatory effects on gene expression
05

Safety considerations

None known
06

Interacting drugs

None known
07

Biomarkers

None known

Beyond the preview

Go deeper on TTC23 antisense RNA 1 (TTC23-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TTC23 antisense RNA 1 (TTC23-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call